Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent

Targeted therapies are a promising alternative to conventional chemotherapy, with an increasing number of therapeutics targeting specific molecular aberrancies in cancer cells. One of the emerging targets for directed cancer treatments is fibroblast growth factor receptors (FGFRs), which are known t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jendryczko, Karolina, Rzeszotko, Jakub, Krzyscik, Mateusz Adam, Szymczyk, Jakub, Otlewski, Jacek, Szlachcic, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636100/
https://www.ncbi.nlm.nih.gov/pubmed/34867353
http://dx.doi.org/10.3389/fphar.2021.748936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636100/
https://www.ncbi.nlm.nih.gov/pubmed/34867353
http://dx.doi.org/10.3389/fphar.2021.748936

Ejemplares similares